(4as,10bs)-4-propyl-3,4a,5,10b-tetrahydro-2h-chromeno[4,3-b][1,4]oxazin-9-ol (CED0152657)

Record Information
Version1.0
Creation Date2026-08-19 06:43:50 UTC
Update Date2026-08-19 06:43:50 UTC
Accession NumberCHEM180128
Identification
Common Name(4as,10bs)-4-propyl-3,4a,5,10b-tetrahydro-2h-chromeno[4,3-b][1,4]oxazin-9-ol
ClassSmall Molecule
Description
(4as,10bs)-4-propyl-3,4a,5,10b-tetrahydro-2h-chromeno[4,3-b][1,4]oxazin-9-ol belongs to the 1-benzopyrans, a subclass of benzopyrans within the organic compounds. This organoheterocyclic compound has the chemical formula C14H19NO3 and an average molecular weight of 249.30 g/mol. It has been found in or released from one recorded source: electrical and electronic equipment specifically related to radio transmission systems.
Contaminant TypeNot Available
Chemical Structure
MOLSDFPDBSMILESInChI
SynonymsNot Available
Chemical FormulaC14H19NO3
Average Molecular Mass249.300 g/mol
Monoisotopic Mass249.136 g/mol
CAS Registry NumberNot Available
IUPAC NameNot Available
Traditional NameNot Available
SMILESNot Available
InChI IdentifierInChI=1S/C14H19NO3/c1-2-5-15-6-7-17-14-11-8-10(16)3-4-13(11)18-9-12(14)15/h3-4,8,12,14,16H,2,5-7,9H2,1H3/t12-,14-/m0/s1
InChI KeyYOILXOMTHPUMRG-JSGCOSHPSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity Values
Toxicity ValueUnitValue RangeOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalReference
2266.0Log mg/kg[1300:4000]RatLD50oralpredictedNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
530Radio Transmission SystemsElectrical & Electronic EquipmentNot Available
Pathways
0 pathways

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
D(3) dopamine receptor structureClick to view 3D structureD(3) dopamine receptorP35462HumansPredicted (SEA)22.9655
D(2) dopamine receptor structureClick to view 3D structureD(2) dopamine receptorP14416HumansPredicted (SEA)34.9543
Click to view 3D structureD(2) dopamine receptorP61169RatPredicted (SEA)27.2472
Click to view 3D structure5-hydroxytryptamine receptor 1AP19327Rattus norvegicusPredicted (SEA)39.5474
D(4) dopamine receptor structureClick to view 3D structureD(4) dopamine receptorP21917HumansPredicted (SEA)42.2721
Click to view 3D structureD(3) dopamine receptorP19020Rattus norvegicusPredicted (SEA)25.6902
Click to view 3D structureSigma non-opioid intracellular receptor 1Q9R0C9Rattus norvegicusPredicted (SEA)93.0298
Sigma non-opioid intracellular receptor 1 structureClick to view 3D structureSigma non-opioid intracellular receptor 1Q99720HumansPredicted (SEA)306.882
Kappa-type opioid receptor structureClick to view 3D structureKappa-type opioid receptorP41145HumansPredicted (SEA)369.706
Mu-type opioid receptor structureClick to view 3D structureMu-type opioid receptorP35372HumansPredicted (SEA)411.667
D(1A) dopamine receptor structureClick to view 3D structureD(1A) dopamine receptorP21728HumansPredicted (SEA)201.785
Delta-type opioid receptor structureClick to view 3D structureDelta-type opioid receptorP41143HumansPredicted (SEA)375.0
Click to view 3D structureMu-type opioid receptorP33535Rattus norvegicusPredicted (SEA)315.834
Click to view 3D structureAlpha-2A adrenergic receptorQ28838Bos taurusPredicted (SEA)12.6894
Click to view 3D structureD(1A) dopamine receptorP18901Rattus norvegicusPredicted (SEA)175.706
D(1B) dopamine receptor structureClick to view 3D structureD(1B) dopamine receptorP21918HumansPredicted (SEA)190.575
5-hydroxytryptamine receptor 1A structureClick to view 3D structure5-hydroxytryptamine receptor 1AP08908HumansPredicted (SEA)621.704
Click to view 3D structureMu-type opioid receptorP42866Mus musculusPredicted (SEA)224.206
Click to view 3D structureSigma non-opioid intracellular receptor 1Q60492Cavia porcellusPredicted (SEA)341.291
Click to view 3D structureKappa-type opioid receptorP41144Cavia porcellusPredicted (SEA)337.243
Click to view 3D structureKappa-type opioid receptorP33534Mus musculusPredicted (SEA)179.131
Click to view 3D structureD(2) dopamine receptorP20288Bos taurusPredicted (SEA)95.521
Click to view 3D structureMu-type opioid receptorP97266Cavia porcellusPredicted (SEA)358.651
Click to view 3D structureSigma intracellular receptor 2Q5BJF2HumansPredicted (SEA)437.201
Click to view 3D structureG_PROTEIN_RECEP_F1_2 domain-containing proteinF7HEV7Macaca mulattaPredicted (SEA)8.56341
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available